Please select your view
Qualification: MA, MBChB, FRCPA, FFOP
Lab: Bella Vista
Areas Of Interest: Breast, endocrine and GIT pathology
Speciality: Anatomical Pathology,Surgical Pathology
Phone: (02) 8882 8794 or (02) 8882 8856
Originally from the UK and having studied medicine at Cambridge and Birmingham universities, Professor Bilous completed his pathology training in New Zealand and Australia. He was for more than 20 years Head of the Tissue Pathology Department at ICPMR, Westmead Hospital in Sydney until 2010. He now works as a Consultant Pathologist for Australian Clinical Labs., formerly Healthscope Pathology. He is also Conjoint Professor of Pathology at Western Sydney University. Professor Bilous has maintained a long standing interest in breast pathology and is a prolific writer on the topic with over 120 publications, predominantly concerning breast cancer and its diagnosis. He is active in several governmental committees and was a member of the Medical Services Advisory Committee of the Commonwealth Department of Health from 2010 to 2014. He is a regular reviewer for a number of journals including Human Pathology, Histopathology, The Medical Journal of Australia, European Journal of Cancer, Journal of Clinical Oncology, Pathology, and The Breast. Professor Bilous was involved in organising the pathology components of BreastScreen, Australia’s National Mammographic Screening Programme. More recently Professor Bilous has been focussing on biomarkers in breast cancer specifically HER2, and he was a member of the ASCO/CAP committee that published its revised recommendations for HER2 testing in breast cancer in 2013, , and the soon to be published second revision in 2017. In addition he has recently designed a CAP training course in HER2 Brightfield ISH testing. Since 2010 he has been travelling widely through South East Asia as head of SPHERE, a programme to improve the quality of testing for biomarkers in breast cancer by convening workshops for pathologists and laboratory scientists in 10 different countries.